- Home
- CAKE vs MYGN Comparison
CAKE vs MYGN Comparison
Compare CAKE & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAKE
- MYGN
- Stock Information
- Founded
- CAKE 1972
- MYGN 1991
- Country
- CAKE United States
- MYGN United States
- Employees
- CAKE N/A
- MYGN N/A
- Industry
- CAKE Restaurants
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CAKE Consumer Discretionary
- MYGN Health Care
- Exchange
- CAKE Nasdaq
- MYGN Nasdaq
- Market Cap
- CAKE 2.8B
- MYGN 744.7M
- IPO Year
- CAKE 1992
- MYGN 1995
- Fundamental
- Price
- CAKE $64.67
- MYGN $5.34
- Analyst Decision
- CAKE Hold
- MYGN Hold
- Analyst Count
- CAKE 14
- MYGN 15
- Target Price
- CAKE $53.71
- MYGN $15.14
- AVG Volume (30 Days)
- CAKE 1.4M
- MYGN 1.3M
- Earning Date
- CAKE 07-29-2025
- MYGN 08-05-2025
- Dividend Yield
- CAKE 1.67%
- MYGN N/A
- EPS Growth
- CAKE 45.67
- MYGN N/A
- EPS
- CAKE 3.19
- MYGN N/A
- Revenue
- CAKE $3,617,673,000.00
- MYGN $831,300,000.00
- Revenue This Year
- CAKE $7.04
- MYGN N/A
- Revenue Next Year
- CAKE $6.10
- MYGN $6.68
- P/E Ratio
- CAKE $20.30
- MYGN N/A
- Revenue Growth
- CAKE 4.42
- MYGN 7.38
- 52 Week Low
- CAKE $33.50
- MYGN $3.81
- 52 Week High
- CAKE $65.99
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- CAKE 66.81
- MYGN 50.85
- Support Level
- CAKE $62.87
- MYGN $4.90
- Resistance Level
- CAKE $65.41
- MYGN $5.83
- Average True Range (ATR)
- CAKE 1.79
- MYGN 0.28
- MACD
- CAKE -0.03
- MYGN 0.04
- Stochastic Oscillator
- CAKE 79.26
- MYGN 54.21
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.